Physician

Allison Elaine Gorrebeeck, MD

According to 2025 Medicare claims, Allison Gorrebeeck, MD (NPI: 1467548628) practices hematology/oncology in the Austin-Round Rock-San Marcos, TX market, with the plurality of this provider's patient population coming from Travis, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1972770303; TIN: 752131429) and primary practice location at 78758-5453. Gorrebeeck is affiliated with the Main Street Rural Health Hickory ACO LLC (ACO ID: A5334) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Gorrebeeck's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 537 traditional Medicare patients, billed 145,991 HCPCS/CPT codes, and received $2,041,053 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,228 prescription claims across 253 beneficiaries totaling $2,313,827 in drug costs, led by Cerdelga (Eliglustat Tartrate). DME data shows 48 claims. Open Payments data shows 38 records totaling $927. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,290,230 and ending at $2,041,053. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $341,905 to $2,313,827. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $47 to $11,096.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.0M2015 Medicare payment: $1,290,230 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,284,258 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,039,527 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $908,898 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,125,034 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,363,288 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,234,910 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,746,239 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,320,935 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,041,053 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201542293,963$1,290,230
2016450129,704$1,284,258
2017494173,808$2,039,527
201845269,572$908,898
201946597,606$1,125,034
2020455107,932$1,363,288
2021454114,262$1,234,910
2022583164,263$1,746,239
2023554132,198$1,320,935
2024537145,991$2,041,053

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.2M$2.3M2015 Drug cost: $341,905 (USD; Tot_Drug_Cst)2016 Drug cost: $801,860 (USD; Tot_Drug_Cst)2017 Drug cost: $812,079 (USD; Tot_Drug_Cst)2018 Drug cost: $676,234 (USD; Tot_Drug_Cst)2019 Drug cost: $736,656 (USD; Tot_Drug_Cst)2020 Drug cost: $1,380,121 (USD; Tot_Drug_Cst)2021 Drug cost: $1,620,224 (USD; Tot_Drug_Cst)2022 Drug cost: $1,963,532 (USD; Tot_Drug_Cst)2023 Drug cost: $1,470,215 (USD; Tot_Drug_Cst)2024 Drug cost: $2,313,827 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015131634$341,905
2016180944$801,860
20172351,324$812,079
2018217802$676,234
2019138609$736,656
2020172909$1,380,121
2021170862$1,620,224
20222401,144$1,963,532
20232421,117$1,470,215
20242531,228$2,313,827

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$6.1K$12K2017 Medicare payment: $5,743 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $12,141 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $9,690 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,597 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,777 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $733 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $5,339 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,022 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R62$5,743
2018N/R94$12,141
2019N/R92$9,690
2020N/R44$3,597
2021N/R47$2,777
2022N/R12$733
2023N/R46$5,339
2024N/R48$2,022

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less120386$102
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more153184$93
80053Blood test, comprehensive group of blood chemicals188535$10
36415Insertion of needle into vein for collection of blood sample219573$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count216580$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CerdelgaEliglustat Tartrate13364$409,140
IbrancePalbociclib23644$350,773
RevlimidLenalidomide12338$251,624
ErleadaApalutamide11380$159,455
EliquisApixaban633,390$64,449

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0656Segmental pneumatic appliance for use with pneumatic compressor, trunkYN/R19$958
E0657Segmental pneumatic appliance for use with pneumatic compressor, chestYN/R18$856
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R11$207

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.38$927Tempus AI, Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Allison Elaine Gorrebeeck, MD?

Tedicare shows public-source Medicare data for Allison Elaine Gorrebeeck, MD (NPI 1467548628), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allison Elaine Gorrebeeck, MD have ACO affiliation data?

Allison Elaine Gorrebeeck, MD is shown with ACO affiliation data for Main Street Rural Health Hickory ACO LLC (MSSP, ACO ID A5334) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Allison Elaine Gorrebeeck, MD?

Allison Elaine Gorrebeeck, MD is linked to TEXAS ONCOLOGY PA (billing NPI 1972770303) in the available physician profile data.

Does Allison Elaine Gorrebeeck, MD have Open Payments data?

Allison Elaine Gorrebeeck, MD has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.